endpoint Launches ConnectionPOINT(TM) - A partnership program
PR89112
endpoint Launches ConnectionPOINT(TM) - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing
SAN FRANCISCO, April 21, 2021 /PRNewswire=KYODO JBN/ --
endpoint Clinical (
), the leading global interactive response technology (IRT(R)) company,
announced today the launch of their partnership program, ConnectionPOINT (TM) (
), the first of its kind in the eClinical technology space. The program's
vision is for a guided convergence of a curated network of eClinical providers
that are leaders in innovation in their domain and dedicated to shifting
towards more thoughtful, next-generation interfacing.
Photo -
https://mma.prnewswire.com/media/1492175/endpoint_Clinical_Launches_ConnectionPOINT.jpg
"While this is our official launch of a partnership program, we have been
collaborating with best-in-class eClinical technology providers to help
transform the future of drug development for over a decade," says Ryan Keane (
), CCO, endpoint. "What we have learned in taking on that commitment of
building relationships and technology for such a long time is that you can see
farther together to drive the industry forward and also have the real ability
to reach, and then exceed, those common aims. ConnectionPOINT is the
culmination of that success. It gives sponsors the peace of mind that
traditionally disparate systems across multiple eClinical providers are not
only communicating seamlessly with one another but pushing boundaries of speed
and data efficiency that do not exist in today's eClinical ecosystem."
The core mission of ConnectionPOINT is to nurture a sustainable, scalable
infrastructure amongst a network of strong, vetted partnerships in support of
eClinical business and technology, predicated on the principles of creating
opportunities, driving innovation, and harmonizing delivery across the
ecosystem.
One of the most compelling applications for these strategic alliances is the
reinvigoration in the alignment of technology and service lines that are
typically viewed as discrete, essential in their own right, and have familiar
legacy intersections – but are now poised to generate new disruptive
opportunities. Here is what some of endpoint's partners are saying about the
already-recognized benefits of ConnectionPOINT and achievements through their
existing technology interfacing with endpoint's IRT:
"When TSS and endpoint came together to explore what our companies could
accomplish together in our space, we knew instantly that more than the easy
wins of legacy touchpoints like basic shipment monitoring was possible," says
Evan Hahn (
), Vice President North America at TSS, a leading global provider of
temperature monitoring technology and services. "All of the conversations at
every level between endpoint and TSS -- from CEOs to technical SMEs to Business
Development -- all quickly resonated with the idea of how far can we push and
prepare this part of the ecosystem for changes coming at the industry and a
greatly increased need for real-time data and functionality sharing around
temperature monitoring. It was clear that endpoint and TSS would quickly
assemble the practical, expected foundation of an integrated approach. Then,
move right behind it with the next generation of 2-way, real-time integration
that works past the shipment level through to the article level, applies to
site inventory as well as the standard shipment need, and is ready to operate
in all frontiers where wireless monitor technology is opening this space up.
That's exactly what we did. That straight-line to a goal doesn't happen without
both organizations being highly aligned."
"One of several direct data collection (DDC) options within encapsia(R),
eSource DDC holds significant promise for the industry as a standalone option,
but its major benefit is bringing simplicity to the complex clinical trials
ecosystem of technology and services. To that end, over 2-and-a-half years ago,
we leveraged the dynamic architecture of encapsia with the hyper-integration
approach endpoint uses in a joint effort to tightly connect systems into one
continuum of experience for the sites and study managers alike," says Temitope
Keyes (
), Executive Director at Cmed Technology. "The encapsia and endpoint teams have
demonstrated a deep commitment to partnership, client success, technological
innovation, and thought leadership in the industry that drives our mutual
ability to deliver a highly harmonized set of systems together successfully. We
provide an intuitive and seamless solution for clinical supplies and clinical
operations workflows, always in compliance while utilizing dynamic data in
near-real-time."
The spectrum of possibilities can extend from deep interfacing of products to
new business models – and require all of the above.
"Systems and tools created by our industry are often very protocol-specific and
driven by the needs of the sponsor. As a result, sites are often left with
myriad applications to learn as well as the associated login credentials to
manage and remember," says Rick Malone (
), Business Development Executive at the McCreadie Group. "We are seeking
solutions that allow research pharmacy teams the flexibility to complete duties
in the workflow they prefer while delivering the protocol-specific needs of the
sponsor. We are thrilled to be working with a like-minded partner in endpoint
that sees the merging of site needs and sponsor needs via our "first of a kind"
integration as a win for all parties involved. McCreadie Group and endpoint
have invested over a year developing a solution that makes life easier for
sites while providing sponsors with improved data integrity and timeliness."
"As much as it is a promise to leverage the collective expertise, strengths,
and obvious benefits of direct interaction between partners, we acknowledge
that it is also creating a challenge to those who join this collective," says
Vincent Puglia, Sr. Director of Strategic Alliances, endpoint. "Consistent
engagement, deepening conversations, breaking down barriers, entertaining new
business models, and tirelessly asking 'what's next?' and 'what else can we
do?' is a considerable commitment. It won't be for everyone, but for those that
adopt a mission like ConnectionPOINT, the quality of the returns cannot be
overstated."
Additional Information
Visit our website for more on endpoint's ConnectionPOINT (
) program.
Connect with endpoint on LinkedIn (
)
About endpoint
endpoint is an interactive response technology (IRT(R)) systems and solutions
provider that supports the life sciences industry. For the past decade, their
customer-obsessed team of professionals has been continuously evolving their
suite of technologies to help Sponsors achieve clinical trial success. Their
dynamic IRT solution, PULSE (R), for patient randomization and management, site
management, and drug supply management and leading-edge clinical supplies
management tool, DRIVE, has proven to maximize the supply chain and minimize
operational costs, and ensure timely and accurate patient dosing. endpoint is
headquartered in San Francisco, California, with offices across the US, EU, and
Asia. www.endpointclinical.com
Contacts:
Catherine Ditzler
Associate Director of Marketing
endpoint Clinical
1-415-688-3424
e: cditzler@endpointclinical.com
SOURCE: endpoint Clinical
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
